跳转至内容
Merck
CN
所有图片(1)

文件

安全信息

386R-1

Sigma-Aldrich

MyoD1 (EP212) Rabbit Monoclonal Primary Antibody

登录查看公司和协议定价

UNSPSC代码:
12352200
NACRES:
NA.41

生物来源

rabbit

质量水平

100
500

偶联物

unconjugated

抗体形式

culture supernatant

抗体产品类型

primary antibodies

克隆

EP212, monoclonal

描述

For In Vitro Diagnostic Use in Select Regions (See Chart)

形式

buffered aqueous solution

种属反应性

human

包装

vial of 0.1 mL concentrate (386R-14)
vial of 0.5 mL concentrate (386R-15)
bottle of 1.0 mL predilute (386R-17)
vial of 1.0 mL concentrate (386R-16)
bottle of 7.0 mL predilute (386R-18)

制造商/商品名称

Cell Marque

技术

immunohistochemistry (formalin-fixed, paraffin-embedded sections): 1:25-1:100

同位素/亚型

IgG

控制

rhabdomyosarcoma

运输

wet ice

储存温度

2-8°C

可视化

nuclear

基因信息

human ... MYOD1(4654)

一般描述

MyoD1, one of the MyoD family of myogenic helix-loop-helix transcription factors, combinedwith myogenin, plays a role in coordinating the differentiation of skeletal muscle. MyoD1 isexpressed in myoblasts before differentiation. Anti-MyoD1 immunostaining identifies cellscommitted to myogenesis in their earliest phase. In conjunction with other markers, antiMyoD1 may be used for the identification of rhabdomyosarcoma.

质量


IVD

IVD

IVD

RUO

联系

MyoD1 Positive Control Slides, Product No. 386S, are available for immunohistochemistry (formalin-fixed, paraffin-embedded sections).

外形

Solution in Tris Buffer, pH 7.3-7.7, with 1% BSA and <0.1% Sodium Azide

制备说明

Download the IFU specific to your product lot and formatNote: This requires a keycode which can be found on your packaging or product label.

其他说明

For Technical Service please contact: 800-665-7284 or email: service@cellmarque.com

法律信息

Cell Marque is a trademark of Merck KGaA, Darmstadt, Germany

法规信息

监管及禁止进口产品

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

N J Sebire et al.
Journal of clinical pathology, 56(6), 412-416 (2003-06-05)
The diagnosis of paediatric solid tumours is often based on small tissue needle biopsies in which many different entities demonstrate a "small round cell tumour" phenotype and in which there may be insufficient tissue to allow the interpretation of diagnostic
Raffaella A Morotti et al.
The American journal of surgical pathology, 30(8), 962-968 (2006-07-25)
Immunohistochemistry remains the current ancillary method of choice in the pathologic evaluation of small blue round-cell tumors. In at least 20% of cases of rhabdomyosarcoma (RMS), it is considered an essential factor in the final and/or differential diagnosis of the

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门